Kura Oncology, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 108
Rang # Quantité totale PI 12 140
Note d'activité PI 2,8/5.0    94
Rang # Activité PI 7 392
Symbole boursier
ISIN US50127T1097
Capitalisation 829M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

32 11
7 7
43 7
1
 
Dernier brevet 2025 - Treatment of hematological malig...
Premier brevet 2014 - Inhibitors of erk and methods of...
Dernière marque 2024 - CASPIAN THERAPEUTICS
Première marque 2021 - TIPGENVI

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical products for the treatment of cancer
2024 Invention Crystalline forms of a menin inhibitor. Described herein are crystalline forms of (S)-4-methyl-5...
Invention Pharmaceutical compositions comprising a menin inhibitor. Described herein are crystalline forms...
Invention Pharmaceutical compositions comprising a menin inhibitor. Provided herein are crystalline forms o...
Invention Crystalline forms of a menin inhibitor. Described herein are crystalline forms of (S)-4-methyl-5-...
Invention Solid forms of a macrocyclic farnesyltransferase inhibitor and formulations thereof, and methods ...
Invention Farnesyltransferase inhibitors for treatment of kras-dependent cancers. Provided herein are metho...
Invention Methods of treating squamous cell carcinoma with a farnesyltransferase inhibitor and a pi3k inhib...
Invention Treatment of non-small cell lung cancer with a combination of 3-amino-3-(1-methyl-1h-imidazol-5-y...
Invention Macrocyclic compounds and compositions, and methods of preparing and using the same. The present...
P/S Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharm...
P/S Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; phar...
Invention Methods for treating hematological malignancies and ewing's sarcoma. The present disclosure prov...
2023 Invention Methods of treating advanced solid tumors. Provided herein are methods of using a compound of For...
Invention A farnesyltransferase inhibitor (fti) and an egfr-tki for use in treating non-small cell lung can...
P/S Pharmaceutical products for the treatment of cancer.
P/S Pharmaceutical products for the treatment of cancer.
P/S Pharmaceutical products for the treatment of cancer. Providing information in the fields of cance...
P/S Pharmaceutical products for the treatment of cancer Providing information in the fields of cancer...
P/S Pharmaceutical products for the treatment of cancer. Providing funds for research in the fields o...
Invention Methods of treating acute leukemia. NPM1KMT2AKMT2A) gene, wherein the methods comprise administer...
Invention Methods of treating head and neck squamous cell carcinoma. Provided herein are methods of tipifa...
Invention Macrocyclic compounds and compositions, and methods of preparing and using the same. The present ...
P/S Providing funds for research of others in the fields of cancer treatment, precision medicine, and...
Invention Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors. The present in...
Invention Methods of treating head and neck squamous cell carcinoma. Provided herein are methods of tipifar...
Invention Treatment of cancer with menin inhibitors and immuno-oncology agents. The present disclosure rela...
Invention Treatment of hematological malignancies with menin inhibitors and p-glycoprotein inhibitors. The...
Invention Treatment of hematological malignancies with menin inhibitors and p-glycoprotein inhibitors. The ...
2022 Invention Macrocyclic compounds having farnesyltransferase inhibitory activity. The present invention relat...
Invention Methods of treating cancer patients with farnesyltransferase inhibitors. The present invention r...
2021 Invention Treatment of hematological malignancies with inhibitors of menin. The present disclosure provide...
Invention Treatment of hematological malignancies with inhibitors of menin. The present disclosure provides...
Invention Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors. The present inv...
2020 Invention Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors. The present inve...
Invention Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors. The present inven...
Invention Methods of treating cancer with farnesyltransferase inhibitors. The present invention relates to...
Invention Methods of treating cancer with farnesyltransferase inhibitors. The present invention relates to ...
Invention Methods of treating cancer patients with farnesyltransferase inhibitors. The present invention re...
2019 Invention Therapies for squamous cell carcinomas. The present invention relates to the field of cancer the...
Invention Therapies for squamous cell carcinomas. The present invention relates to the field of cancer ther...
Invention Treatment of adenocarcinomas with mapk pathway inhibitors. The present disclosure provides method...
Invention Synthesis of tipifarnib. Provided herein are methods of preparing a desired enantiomer 6-[amino(4...